share_log
Reuters ·  Apr 25 07:30
Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment